BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7008160)

  • 21. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R; Lévy M; Gubler MC; Broyer M; Habib M
    Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial: Glomerulonephritis, complement and C3NeF.
    Fearon DT
    N Engl J Med; 1976 Feb; 294(9):495-7. PubMed ID: 1246336
    [No Abstract]   [Full Text] [Related]  

  • 23. Circulating complement levels and C3 glomerulopathy.
    Fervenza FC; Sethi S
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1829-31. PubMed ID: 25341723
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (MPGN).
    Belgiojoso GB; Tarantino A; Bazzi C; Colasanti G; Guerra L; Durante A
    Clin Nephrol; 1976 Jul; 6(1):303-10. PubMed ID: 782750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C3 metabolism in acute glomerulonephritis: implications for sites of complement activation.
    Endre ZH; Pussell BA; Charlesworth JA; Coovadia HM; Seedat YK
    Kidney Int; 1984 Jun; 25(6):937-41. PubMed ID: 6236326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement receptors and cell associated complement components.
    McConnell I; Lachmann PJ
    Immunol Commun; 1977; 6(2):111-32. PubMed ID: 324894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherited deficiency of the second component of complement (C2) with membranoproliferative glomerulonephritis.
    Kim Y; Friend PS; Dresner IG; Yunis EJ; Michael AF
    Am J Med; 1977 May; 62(5):765-71. PubMed ID: 860727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical applications of complement measurements in rheumatic diseases.
    Goldstein IM
    Am J Med Sci; 1975; 269(2):172-82. PubMed ID: 1096603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The reactivity of the complement system.
    Hadding U
    Monogr Allergy; 1977; 12():36-45. PubMed ID: 335218
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (Type I MPGN).
    Levy M; Gubler MC; Sich M; Beziau A; Habib R
    Clin Immunol Immunopathol; 1978 Aug; 10(4):477-92. PubMed ID: 357058
    [No Abstract]   [Full Text] [Related]  

  • 31. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C3, C4 and C5: the thioester site.
    Law SK; Dodds AW
    Biochem Soc Trans; 1990 Dec; 18(6):1155-9. PubMed ID: 2088831
    [No Abstract]   [Full Text] [Related]  

  • 33. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
    Machado AJ; Gazzinelli G; Pellegrino J; Dias de Silva W
    Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484
    [No Abstract]   [Full Text] [Related]  

  • 34. Complement activation in acute glomerulonephritis in children.
    Levy M; Sich M; Pirotzky E; Habib R
    Int J Pediatr Nephrol; 1985; 6(1):17-24. PubMed ID: 3997368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biochemistry of complement.
    Porter RR; Reid KB
    Nature; 1978 Oct; 275(5682):699-704. PubMed ID: 703835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the classic complement pathway in patients with the C3 nephritic factor.
    McLean RH; Siegel NJ; Kashgarian M
    Nephron; 1980; 25(2):57-64. PubMed ID: 6986570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Persistent C4 deficiency in a 26-month-old girl with mesangial glomerulonephritis and deposits of IgG and C3].
    Buffatti G; Borgo G; Lupo A
    Minerva Pediatr; 1977 Mar; 29(9):593-8. PubMed ID: 876007
    [No Abstract]   [Full Text] [Related]  

  • 38. [Alternate complement pathway in Behçet disease (author's transl)].
    Kogure M; Ono Y
    Nippon Ganka Gakkai Zasshi; 1975 Mar; 79(3):172-6. PubMed ID: 1171606
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of complement in thrombogenesis. I. Complement-dependent coagulation in a model system.
    Abdulla YH; McFarlene E
    Atherosclerosis; 1977 Nov; 28(3):257-70. PubMed ID: 597343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum complement components in patients with trachoma.
    Sen DK; Sarin GS; Hiranandani M; Baveja UK
    Br J Ophthalmol; 1985 Sep; 69(9):707-10. PubMed ID: 3876110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.